Analyst Recommendations

1.31 -0.02(-1.14%)07/03/2024
CytomX Therapeutics Inc (CTMX)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Market Perform3
Neutral2
Buy1
Outperform1
Overweight1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades